April 2010 – The CenterWatch Monthly : PDF

What’s in a Name? Site Groups in the Post-SMO Era

Part I of a Two-part Series
Site group business models come in almost as many varieties as site groups themselves—with the names to match.

Moving Toward a Patient-Centered Clinical Trial Model

Clinical research is shifting toward greater patient engagement as the biopharmaceutical industry explores new ways to integrate various healthcare trends and technologies that could allow patients to become more actively involved in clinical trials. These trends have the potential to bring about a shift from the industry’s current site-centric model to a more patient-centered model.

Michael J. Fox Foundation Gives German IIT New Life

The Michael J. Fox Foundation (MJFF) has awarded $1.1 million to an investigator-initiated collaboration between the German Parkinson Study Group (GPS) and the Parkinson Study Group (PSG) in the U.S. to evaluate the disease-modifying potential of transdermal nicotine on Parkinson’s.

Eye On: Addictions

Of the approximately 6 million opioid addicts worldwide, about half are addicted to heroin and other illicit drugs, whereas the other half are addicted to prescription medications including oxycontin, methadone and codeine. Because of the strict regulations involving treatment of opioid addiction with methadone, only a limited number of facilities are authorized to provide these treatments, and there is a great need for treatments with less potential for abuse and diversion.

• Month in Review
• In the Pipeline
• Opportunities Initiating
• TrialWatch